22 min listen
Emerging Practice Strategies for PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma
Emerging Practice Strategies for PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma
ratings:
Length:
20 minutes
Released:
Jun 8, 2021
Format:
Podcast episode
Description
Dr Nastoupil and Dr Dreyling discuss PI3K inhibition in follicular lymphoma, including practical considerations and treatment selection. Credit available for this activity expires: 6/7/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/952387?src=mkm_podcast_addon_952387
Released:
Jun 8, 2021
Format:
Podcast episode
Titles in the series (100)
The Latest in PAD: Guidelines, Data, and Expert Interpretation: Dr Bauersachs, Brodmann, and Aboyans review the latest recommendations antithrombotic therapy in patients with PAD. --- Full URLs: Earn Credit / Learning Objectives & Disclosures:... by Keeping Current CME